Scaling and value quantification of multimodal molecular fusion at foundation-model scale
Determine the feasibility and performance characteristics of scaling multimodal molecular representation fusion architectures—such as combinations of graph, text (SMILES), and 2D/3D representations—to pre-training on datasets exceeding 100 million molecules, and quantify the contribution of such multimodal combinations to downstream drug discovery tasks across diverse benchmarks.
References
While the molecular use-case has been explored in several publications, primarily in the context of combining graph with a text-based model or 2-dimensional and 3-dimensional molecular representations, the scaling of such approach to large scale pre-training ($>100 \text{M}$) and the quantification of the value of such combinations on downstream drug discovery tasks remain an open question.
These studies establish that representation diversity can be useful, but they also leave open how much additional architecture is needed to integrate strong predictors.